Stocks360

Vanguard PRIMECAP Fund Investor Shares (VPMCX)

Stock analysis · NASDAQ · Financial Services · Asset Management

Share: Facebook X WhatsApp SMS
$216.48

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$88.77B
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
1.05
Day Range
$216.48 – $222.52
52-wk Range
$168.06 – $232.97
Avg Volume
N/A
Volume
0.00

Vanguard PRIMECAP Fund Investor Shares (VPMCX) is a publicly traded company in the Financial Services sector. Latest price: $216.48. Market cap $88.77B. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $198.46 2026-10-30 · $216.48 (+9.08%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Vanguard PRIMECAP Fund Investor Shares

This growth-oriented fund primarily invests in large and mid-sized companies, operating with a long-term outlook, exceptionally low portfolio turnover, and a time-tested investment approach. Established in 1984, PRIMECAP Management Company, the fund's advisor, employs a unique strategy where several portfolio managers independently oversee distinct segments of the portfolio. This multi-manager structure is designed to promote a variety of investment viewpoints. A key risk factor is the fund's potential for significant concentration in a handful of sectors, most notably technology and health care. This sectoral focus can lead to considerable short-term performance fluctuations, particularly when these industries experience strong rallies or downturns. Investors seeking to enhance an already diversified portfolio, and who possess a long-term investment horizon, may find this fund suitable as a supplementary holding.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap